Sanofi Genzyme Competitors and Similar CompaniesClear all
Biogen's competitors and similar companies include Amgen.
 Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. | |
Founding Date | Founding Date 1978 | Founding Date 1980 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more |
Employees | Employees 7,605 | Employees 25,200 |
Valuation ($) | Valuation ($) 26.7 b | Valuation ($) 170.4 b |
Financial | ||
Revenue (est.) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) $36.8b (FY, 2025) |
Cost of goods | Cost of goods $2.4b (FY, 2025) | Cost of goods $12b (FY, 2025) |
Gross profit | Gross profit $7.5b (FY, 2025) | Gross profit $24.7b (FY, 2025) |
Net income | Net income $1.3b (FY, 2025) | Net income $7.7b (FY, 2025) |
Operating ⚠ | ||
Phase I Trials Products | Phase I Trials Products 4 (FY, 2024) | Phase I Trials Products 20 (FY, 2020) |
Phase II Trials Products | Phase II Trials Products 6 (FY, 2024) | Phase II Trials Products 5 (FY, 2020) |
Phase III Trials Products | Phase III Trials Products 11 (FY, 2024) | Phase III Trials Products 11 (FY, 2020) |
For sources of this data, please see the company profile
View Company Profiles
Amgen
HQ
Thousand Oaks, US
Employees
25,200
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View company